Virological and Serological Characterization of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination

Francesca Colavita, Silvia Meschi, Cesare Ernesto Maria Gruber, Martina Rueca, Francesco Vairo, Giulia Matusali, Daniele Lapa, Emanuela Giombini, Gabriella De Carli, Martina Spaziante, Francesco Messina, Giulia Bonfiglio, Fabrizio Carletti, Eleonora Lalle, Lavinia Fabeni, Giulia Berno, Vincenzo Puro, Antonino Di Caro, Barbara Bartolini, Giuseppe Ippolito, Maria Rosaria Capobianchi, Concetta Castilletti on behalf of INMI Covid-19 laboratory surveillance team
doi: https://doi.org/10.1101/2021.09.21.21263882

Data Availability

Sequencing data that support the findings of this study have been deposited in GISAID; the list of the accession codes is available from the corresponding author on reasonable request. The other data used and/or analyzed during the current study are available, only for sections non-infringing personal information, from the corresponding author upon request.

Back to top
Posted September 22, 2021.
Download PDF
Data/Code
Email
Virological and Serological Characterization of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination
Francesca Colavita, Silvia Meschi, Cesare Ernesto Maria Gruber, Martina Rueca, Francesco Vairo, Giulia Matusali, Daniele Lapa, Emanuela Giombini, Gabriella De Carli, Martina Spaziante, Francesco Messina, Giulia Bonfiglio, Fabrizio Carletti, Eleonora Lalle, Lavinia Fabeni, Giulia Berno, Vincenzo Puro, Antonino Di Caro, Barbara Bartolini, Giuseppe Ippolito, Maria Rosaria Capobianchi, Concetta Castilletti
medRxiv 2021.09.21.21263882; doi: https://doi.org/10.1101/2021.09.21.21263882
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area